Arm Holdings plc - American Depositary Shares (ARM)
239.69
-1.85 (-0.77%)
NASDAQ· Last Trade: Jul 31st, 6:33 PM EDT
Nano Nuclear Energy is riding a wave of good news.
Via The Motley Fool · July 31, 2026
Church & Dwight (NYSE:CHD) reported second-quarter results that exceeded its prior outlook, driven by broad-based volume growth, market-share gains and contributions from innovation. The company raised its full-year sales, earnings and cash-flow outlook despite what management described as a dynamic
Via MarketBeat · July 31, 2026
Lam Research gets a nice chunk of its revenue from sales of memory manufacturing equipment, and that's great news for its future.
Via The Motley Fool · July 31, 2026
ARM Holdings (NASDAQ:ARM) Fiscal Q1 Results Beat Estimates but Guidance Disappoints, Shares Drop 6%chartmill.com
Via Chartmill · July 29, 2026
Arm delivered solid results, but all eyes are on its upcoming AGI CPU chip.
Via The Motley Fool · July 31, 2026
Household products company Church & Dwight (NYSE:CHD) announced better-than-expected revenue in Q2 CY2026, with sales up 1.6% year on year to $1.53 billion. ...
Via StockStory · July 31, 2026
4 Healthy Habits to Prepare the Body and Mind for Back-to-School
(BPT) - As the busy back-to-school season approaches, establishing healthy routines now can help students and their families feel more physically and mentally prepared for a successful start to the school year.
Via Brandpoint · July 31, 2026
Custom letterpress tags bring a real touch of warmth and texture to your packages and gifts. People notice details. A simple paper wrap feels different whe
Via Talk Markets · July 31, 2026
House of Doge shares gained 18.92% after hours following disclosure of a $1.4 million debt note tied to CleanCore shares.
Via Benzinga · July 30, 2026
Revenue hit $1.31 billion with strong international growth and margin expansion.
Via The Motley Fool · July 30, 2026
Arm stock rallied after reporting record Q1 earnings and revenue beat. JPMorgan and Needham maintain buy ratings on positioning in AI.
Via Benzinga · July 30, 2026
Arm Holdings Plc (NASDAQ:ARM) shares are surging Thursday after the chip architecture company delivered a record first quarter.
Via Benzinga · July 30, 2026
Investors are buying back into chip stocks, and Arm just delivered a promising quarterly report.
Via The Motley Fool · July 30, 2026
Intel and AMD dominate the server CPU market, but Nvidia seems to be becoming an influential player in this space.
Via The Motley Fool · July 30, 2026
The Fed Held, The Bond Market Called The Bluff, and Oil Did The Restchartmill.com
Via Chartmill · July 30, 2026
Despite exceeding Wall Street’s estimates for both revenue and non-GAAP profit, Intel’s second quarter results prompted a significant negative market reactio...
Via StockStory · July 30, 2026
ARM (NASDAQ:ARM) reported record first-quarter fiscal 2027 results, with revenue rising 22% year over year to $1.29 billion as demand for its computing platform expanded across cloud AI infrastructure, edge devices and physical AI applications.
Chief Executive Officer Rene Haas said the company del
Via MarketBeat · July 29, 2026
Here's a look inside the Q1 earnings report from Arm Holdings.
Via Benzinga · July 29, 2026
The industry's biggest future bottleneck won't be memory chips but rather a lack of electricity.
Via The Motley Fool · July 29, 2026
The edge banding machine, is used to band the straight and curved panel edges for custom furniture production. A woodworking edge banding machine falls int
Via Talk Markets · July 29, 2026
Neck pain, numbness in the arms, and reduced mobility can significantly affect your daily life. When non-surgical treatments no longer provide relief, adva
Via Talk Markets · July 29, 2026
Most enterprise AI apps today simply wait for an LLM to respond. That changes when agents begin writing and running code.
Via The Motley Fool · July 28, 2026
Arm Holdings stock fell over 9% as AI trade jitters hit tech shares. Get key insights on technical levels, earnings estimates, and analyst targets ahead of results.
Via Benzinga · July 28, 2026
Altimmune (NASDAQ:ALT) reported positive top-line results from its Phase II RECLAIM trial evaluating pemvidutide in adults with moderate to severe alcohol use disorder, or AUD, with the company saying the study met its primary endpoint and several secondary measures after 24 weeks of treatment.
The
Via MarketBeat · July 28, 2026
The loss ran through the accounting. The payout runs on cash.
Via The Motley Fool · July 28, 2026